Brief: EyePoint Pharmaceuticals Reports Q3 2024 Financial Results And Highlights Recent Corporate Developments
07/11/2024 12:41
Nov 7 (Reuters) - EyePoint Pharmaceuticals Inc EYPT.O :
* EYEPOINT PHARMACEUTICALS REPORTS THIRD QUARTER 2024
FINANCIAL
RESULTS AND HIGHLIGHTS RECENT CORPORATE DEVELOPMENTS
* EYEPOINT PHARMACEUTICALS INC: $161.0 MILLION
OVERSUBSCRIBED
EQUITY FINANCING EXTENDS CASH RUNWAY INTO 2027
Source text: ID:nGNXXdlw7
Further company coverage: EYPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EyePoint
See all newsUS RESEARCH ROUNDUP-Axon Enterprise, Williams-Sonoma, Xcel Energy
US STOCKS ON THE MOVE-CoreWeave, Moderna, Datadog
U.S. STOCKS ON THE MOVE-Amazon, CoreWeave, Moderna
U.S. STOCKS ON THE MOVE-Centrus Energy, Disc Medicine, Crypto
EyePoint to halve workforce after experimental drug fails second late-stage trial (updated)